Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate

scientific article

Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1041999084
P356DOI10.1186/S13071-016-1932-4
P932PMC publication ID5217559
P698PubMed publication ID28057055

P50authorLiwang CuiQ60429811
Takafumi TsuboiQ63860522
P2093author name stringFei Liu
Qi Fan
Enjie Luo
Wenqi Zheng
Yaming Cao
Qingyang Liu
Yiwen He
Gregory B Humphreys
P2860cites workAlgae-produced Pfs25 elicits antibodies that inhibit malaria transmissionQ21134576
A molecular marker of artemisinin-resistant Plasmodium falciparum malariaQ22061872
Continuous cultures of fused cells secreting antibody of predefined specificityQ26776979
Characterization of a new phosphatase from PlasmodiumQ27670486
A NIMA-related protein kinase is essential for completion of the sexual cycle of malaria parasitesQ27972563
Genome-wide functional analysis of Plasmodium protein phosphatases reveals key regulators of parasite development and differentiationQ27972615
Characterisation of Plasmodium invasive organelles; an ookinete microneme proteomeQ27972689
Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccineQ27974539
A comprehensive evaluation of rodent malaria parasite genomes and gene expressionQ28250679
A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analysesQ28301446
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activityQ28740771
The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitroQ30039034
Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium bergheiQ30043378
Reverse genetics screen identifies six proteins important for malaria development in the mosquitoQ30046142
SOAP, a novel malaria ookinete protein involved in mosquito midgut invasion and oocyst developmentQ30046679
Plasmodium invasion of mosquito cells: hawk or dove?Q44145510
Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopesQ44146493
Ookinete antigens of Plasmodium berghei. Appearance on the zygote surface of an Mr 21 kD determinant identified by transmission-blocking monoclonal antibodies.Q44146592
The development of Plasmodium ookinetes in vitro: an ultrastructural study including a description of meiotic divisionQ44153021
Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivoQ44169602
A semi-empirical method for prediction of antigenic determinants on protein antigensQ52466148
High efficiency transfection of Plasmodium berghei facilitates novel selection proceduresQ30080002
Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.Q30390705
Vital functions of the malarial ookinete protein, CTRP, reside in the A domainsQ30581460
A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coliQ33485233
A research agenda for malaria eradication: vaccinesQ33818046
Child mortality and malaria transmission intensity in AfricaQ34207756
The systematic functional analysis of Plasmodium protein kinases identifies essential regulators of mosquito transmissionQ34293946
Transmission-blocking vaccines.Q34680152
P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functionsQ34729130
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivaxQ35088997
N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activityQ35138720
A proteomic analysis of malaria biology: integration of old literature and new technologiesQ35975136
Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive SelectionQ36062237
Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvantsQ36267184
Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquitoQ36351262
In vitro formation of ookinetes and functional maturity of Plasmodium berghei gametocytesQ36411839
Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in miceQ36670217
The microneme proteins CTRP and SOAP are not essential for Plasmodium berghei ookinete to oocyst transformation in vitro in a cell free systemQ36718587
Malaria transmission-blocking vaccines: the bonus of effective malaria controlQ36785468
Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium bergheiQ36958620
Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivaxQ37025716
Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settingsQ37119364
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidatesQ37170062
An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccinesQ37243605
Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaQ37253966
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasiteQ37583147
Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refoldingQ37713285
Toward the development of effective transmission-blocking vaccines for malariaQ38322553
Naturally acquired immunity to sexual stage P. falciparum parasites.Q38689928
Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidatesQ39018502
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodiesQ39467691
Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmissionQ39679346
Copolymer adjuvants in malaria vaccine development.Q40747453
Transmission blocking malaria vaccines: Assays and candidates in clinical developmentQ40979878
von Willebrand Factor A domain-related protein, a novel microneme protein of the malaria ookinete highly conserved throughout Plasmodium parasitesQ42654983
Transmission blocking malaria vaccinesQ44145217
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectPlasmodium bergheiQ65021
malaria vaccineQ6741353
infectious diseaseQ18123741
PIMMS43 proteinQ56562267
PIMMS43 protein, putativeQ56717297
malaria transmissionQ56928847
PIMMS43 protein, putativeQ59749164
PIMMS43 protein, putativeQ59881727
PIMMS43 proteinQ59916944
PIMMS43 protein, putativeQ59959833
PIMMS43 protein, putativeQ59982378
PIMMS43 protein, putativeQ59982760
PIMMS43 protein, putativeQ59982832
PIMMS43 protein, putativeQ60000250
PIMMS43 protein, putativeQ60008073
PIMMS43 protein, putativeQ61616988
ookineteQ123923963
P304page(s)8
P577publication date2017-01-05
P1433published inParasites and VectorsQ7135941
P1476titleFunctional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate
P478volume10

Reverse relations

described by source (P1343)
Q56562267PIMMS43 protein
Q59916944PIMMS43 protein
Q56717297PIMMS43 protein, putative
Q59749164PIMMS43 protein, putative
Q59881727PIMMS43 protein, putative
Q59959833PIMMS43 protein, putative
Q59982378PIMMS43 protein, putative
Q59982760PIMMS43 protein, putative
Q59982832PIMMS43 protein, putative
Q60000250PIMMS43 protein, putative
Q60008073PIMMS43 protein, putative
Q61616988PIMMS43 protein, putative

cites work (P2860)
Q90732916An MFS-Domain Protein Pb115 Plays a Critical Role in Gamete Fertilization of the Malaria Parasite Plasmodium berghei
Q56358374Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential
Q60922149Druggable Targets in Cyclic Nucleotide Signaling Pathways in Apicomplexan Parasites and Kinetoplastids against Disabling Protozoan Diseases in Humans
Q92358725Malaria.tools-comparative genomic and transcriptomic database for Plasmodium species
Q58606303Metanetwork Transmission Model for Predicting a Malaria-Control Strategy
Q90281173PIMMS43 is required for malaria parasite immune evasion and sporogonic development in the mosquito vector
Q59923959The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes

Search more.